electroCore Lowers FY2026 Sales Guidance from $41.642M to $41.600M vs $41.921M Est
electroCore (NASDAQ:ECOR) lowers FY2026 sales outlook from $41.642 million to $41.600 million vs $41.921 million estimate.
Read original at benzingaStocks · News reference
electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.40) by 17.5 percent. This is a 25 percent increase over losses of $(0.44) per share from the same
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
electroCore (NASDAQ:ECOR) lowers FY2026 sales outlook from $41.642 million to $41.600 million vs $41.921 million estimate.
Read original at benzingaelectroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine company, announced it will present at Planet MicroCap Las Vegas 2026 on June 17-18 at the Bellagio Resort & Casino. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings to discuss the company's strategy and growth opportunities.
Read original at globenewswire-inc